Addiction Statistics in Australia

Substance use has long been a public health concern in Australia, affecting not only individuals but also families, workplaces, and entire communities. Although Australia has made strides in tobacco control and harm-reduction strategies, patterns of drug and alcohol use continue to evolve—sometimes in surprising ways.

Over the last five years, data show both promising declines in youth smoking and simultaneous upticks in cocaine, e-cigarette, and methamphetamine use among certain demographics. Regional disparities highlight how location, socioeconomic factors, and cultural contexts shape addiction patterns. Here, we examine current trends in prevalence, treatment access, health burdens, and the impact of government programs to gain a clearer picture of Australia’s substance abuse landscape.

Key Statistics

• Approximately 18% of Australians (14+) used an illicit drug in the past year.
• Close to 35% of young adults (18–24) reported recent illicit drug use—the highest of any age group.
• Indigenous Australians experience rates of illicit drug use roughly 1.4 times higher than non-Indigenous Australians.
• In 2022–23, publicly funded alcohol and other drug services provided nearly 235,500 treatment episodes to about 131,500 clients.

Why Regional and Demographic Trends Matter

Understanding where and how different groups use substances is crucial for tailoring effective prevention and treatment strategies. Patterns vary significantly between states and territories, Indigenous and non-Indigenous communities, urban and rural contexts, and among different age and gender groups.

Regional Substance Preferences

• Cannabis remains the most commonly used illicit drug across all states, with around 11–13% of people (14+) reporting past-year use in most jurisdictions.
• Cocaine use shows an urban concentration—higher in major cities like Sydney—while methamphetamine (“ice”) has exerted a more pronounced impact in regional areas of Western Australia, Queensland, and South Australia.
• Alcohol consumption is notably higher in the Northern Territory than elsewhere, contributing to elevated rates of alcohol-related hospitalizations and violence.
• Tobacco smoking is trending downward nationwide but remains disproportionately high in lower-income and remote regions.

Indigenous vs. Non-Indigenous Rates

• Around 27% of Indigenous Australians (15+) report using an illicit drug in the past year—significantly higher than the national average.
• Tobacco and alcohol misuse contribute heavily to health inequalities, with Indigenous smoking rates around three times higher than those of non-Indigenous populations.
• Disease burden from illicit drugs is 3.7 times higher for Indigenous communities, emphasizing the interplay of historical trauma, socioeconomic disadvantage, and limited healthcare access.
• Despite some improvements—like programs that drastically reduced petrol sniffing—substance abuse remains a leading factor in the “Closing the Gap” framework for Indigenous health.

Urban vs. Rural Patterns

• Remote/Very Remote Areas: Higher incidence of illicit drug use overall (about 21% recent use) and significantly higher rates of daily smoking (around 20%).
• Major Cities: While illicit drug prevalence is also high, more resources exist for treatment, and certain substances (e.g., cocaine) are more common in urban nightlife.
• Alcohol-related harms (including violence and injury) can be particularly severe in rural regions, often linked to social isolation and fewer service options.

Age Distribution

• Teens (14–17): Usage rates are lower than in older groups, although vaping is a growing concern.
• Young Adults (18–24): Highest rates of illicit drug use (up to 35%). Heavy episodic drinking also peaks in this range.
• Middle-Aged (25–44): Substance use remains significant but begins to decline compared to the early 20s. Prescription opioid and benzodiazepine misuse can emerge here.
• Older Adults (50+): Historically low illicit drug rates, but a notable rise in continued cannabis and prescription medication misuse among Baby Boomers.

Gender-Specific Patterns

• Males have traditionally shown higher rates of substance use across most drug categories and make up around two-thirds of drug overdose deaths.
• Women are narrowing the gap—particularly young women who show increased rates of illicit drug use (cannabis, alcohol, nicotine vaping).
• Women often face unique barriers to treatment, such as childcare responsibilities, and higher rates of co-occurring mental health issues.

Treatment Accessibility and Gaps

Timely access to addiction treatment is pivotal for reducing individual harm and broader social costs. While Australia boasts a substantial public treatment network, barriers persist.

• Publicly Funded Services: Approximately 1,280 agencies offer alcohol and other drug (AOD) treatment services, providing over 235,500 episodes of care each year. Most are operated by NGOs, often at little or no cost to clients.
• Waiting Times: Demand often exceeds capacity. Residential rehabilitation, in particular, can entail waitlists of 3–6 months, which risks losing people in crisis.
• Geographical Inequity: Services cluster in metro areas, leaving rural and remote populations underserviced. Telehealth has expanded but is not a panacea for severe dependency.
• Private vs. Public: While private facilities exist—often with shorter wait times—they remain cost-prohibitive for many, making the public/NGO sector the primary lifeline for most Australians with addiction.

Sponsored

Online Therapy Can Help

Over 3 million people use BetterHelp. Their services are:

• Professional and effective
• Affordable and convenient
• Personalized and discreet
• Easy to start

Find a Therapist

Answer a few questions to get started

Healthcare Cost Burden

Substance abuse exacts a significant toll on Australia’s healthcare system and economy:

• Hospital Admissions: Tens of thousands of drug-related hospitalisations annually (excluding alcohol and tobacco), averaging over 140 hospital stays per day from illicit drug complications alone.
• Drug-Induced Deaths: In 2022, around 1,640 drug-induced deaths occurred (nearly all from overdose), with poly-drug toxicity common.
• Long-Term Disease Burden: Illicit drug use accounts for roughly 3% of total disease burden nationwide, factoring in conditions like HIV, hepatitis C, and mental health disorders.
• Economic Costs: Combined tangible and intangible costs for alcohol, tobacco, and illicit drugs have been estimated in the tens (and even hundreds) of billions of dollars annually.

Sponsored

Get Professional Help

BetterHelp can connect you to an addiction and mental health counselor.

Find a Therapist

Answer a few questions to get started

Success Rates of Treatment

Though long-term abstinence can be elusive for chronic users, Australian programs show promising indicators of effectiveness:

• High Completion Rates: Many government-funded and NGO-led services report 80–90% of treatment episodes end with a planned completion, demonstrating strong retention.
• Reduced Harms: Opioid substitution therapy cuts mortality risk substantially for dependent users; needle-exchange programs are credited with preventing thousands of HIV and hepatitis infections.
• Challenges in Measurement: True “success” extends beyond abstinence—lower use and improved health/function also count. Many people cycle through multiple episodes before achieving stable recovery.

Government Program Effectiveness

Australia’s National Drug Strategy (2017–2026) frames policies around supply reduction, demand reduction, and harm reduction.

• Tobacco Control: Among the world’s most stringent, leading to some of the lowest smoking rates (around 11% of adults daily).
• Harm Reduction: Needle-syringe programs, supervised injecting centers, and broad opioid substitution coverage have kept overdose mortality well below North American levels.
• Alcohol Policy: Random breath testing and certain local restrictions show success, but overall alcohol consumption remains high; more aggressive strategies (e.g., minimum unit pricing) are under evaluation.
• Law Enforcement vs. Public Health: Critics note that around two-thirds of illicit drug spending goes to policing, with under 10% to harm reduction. While seizures disrupt supply short term, they have not decisively lowered prevalence.

Sponsored

Phone, Video, or Live-Chat Support

BetterHelp provides therapy in a way that works for YOU. Fill out the questionnaire, get matched, begin therapy.

Get Started

Answer a few questions to get started

Socioeconomic Correlations

Substance misuse both stems from and perpetuates social disadvantage.

• Smoking strongly correlates with lower income and education, with daily smoking ~20% in the most disadvantaged areas vs. 7% in advantaged areas.
• Alcohol’s heaviest harms (disease, violence) often fall on lower SES groups, even though high-risk drinking per se is not restricted to these communities.
• Illicit Drugs vary by status: “expensive” recreational drugs (cocaine, MDMA) trend higher in affluent areas, while crystal meth and inhalants see more use in disadvantaged regions.
• Poly-Substance Use intensifies in low-SES contexts, compounding health, legal, and economic hardships.

Workplace and Family Impact

Employment and Productivity

• Absenteeism: Drug use leads to missed workdays; alcohol misuse alone accounts for millions of lost productivity days.
• Accidents: Safety-critical industries (construction, mining) are particularly vulnerable to workplace injuries involving substance impairment.
• Presenteeism: Hungover or withdrawing employees may be physically present but function at diminished capacity.

Family Consequences

• Domestic Violence: Alcohol is implicated in as many as one in four (or more) family violence incidents, escalating injury severity.
• Child Welfare: Up to 50–80% of child protection cases involve parental substance abuse, contributing significantly to foster care demands.
• Economic and Emotional Strain: Addiction often leads to financial hardship, marital breakdown, and intergenerational trauma within affected families.

Poly-Substance Use

Most individuals seeking treatment report more than one drug of concern:

• Common Combinations: Cannabis and nicotine often co-occur as secondary substances. Methamphetamine users may also rely on benzodiazepines to manage “come-down” symptoms.
• High Overdose Risk: Mixing opioids with benzodiazepines or alcohol is a frequent factor in fatal overdoses.
• Treatment Complexities: Poly-substance use requires integrated care. Detox protocols must address multiple dependencies for safe stabilization.

International Comparisons

Australia’s substance use profile is similar to other high-income Western nations but stands out in key respects:

• Prevalence: Cannabis use is particularly high. Overall illicit drug use (~18% annually) surpasses that of the UK but sits below or close to U.S. levels.
• Mortality: Drug-induced deaths remain far lower than in the U.S., largely due to fewer synthetic opioid (fentanyl) infiltrations and more comprehensive harm-reduction infrastructure.
• Tobacco: Rates are among the lowest globally, reflecting robust public health campaigns.
• Policy Innovations: Needle-syringe programs, supervised injecting facilities, and tobacco plain packaging have garnered international recognition, although enforcement-focused spending remains significant.

Australia’s experience underscores how evidence-based policies can reduce harms even when overall substance use rates remain relatively high. It also reveals the continued tension between penal enforcement and public health strategies.

Australia’s modern addiction landscape reveals a complex interplay: high rates of cannabis, rising experimentation with “party drugs,” persistent and severe harms from alcohol, ongoing methamphetamine challenges, and a strong but imperfect network of harm-reduction and treatment services. Socioeconomic and demographic factors shape the burden on different communities—urban vs. remote, Indigenous vs. non-Indigenous, lower vs. higher income.

Though Australia has recorded impressive successes—especially in tobacco reduction—challenges endure. Treatment availability still lags behind demand, with long waitlists in many regions. Alcohol remains entrenched culturally, fueling violence and chronic disease. Shifting patterns like vaping and the growth of new psychoactive substances test the agility of current policies. Yet, Australia’s balanced approach—emphasizing harm reduction while refining prevention, policing, and treatment—demonstrates that real progress is possible.

Looking ahead, policy focus appears to be moving steadily toward expanded treatment capacity, greater investment in youth prevention, and ongoing innovation in harm reduction (such as broader pill testing at music festivals). This approach aims not only to reduce the immediate toll of addiction but also to foster a healthier environment for all Australians, from early adolescence through to older age. If bolstered by adequate funding and a strong public health framework, the country’s strategies have the potential to curtail substance-related harms more effectively and continue setting global precedents in drug policy.

Ultimately, the data reinforce that substance abuse is far more than an individual problem; it intersects with wider issues of social equity, mental health, and community resilience. Policymakers, health professionals, and local communities share a collective responsibility to ensure that accessible, evidence-based support is available, and that policies remain flexible to tackle the shifting terrain of addiction in Australia.

Sponsored

Get matched with an affordable mental health counselor

Find a Therapist

Answer a few questions to get started